Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epaxal Concomitant Administration in Toddlers
NCT01307436Phase 3Completed
- Sponsor
- Crucell
- Start
- Mar 2007
- Primary completion
- Jul 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Epaxal Junior in hepatitis A (HAV), sponsored by Crucell. Started Mar 2007; status: completed.
02
Drugs
Epaxal Junior
03
Conditions
hepatitis A (HAV)
Beyond the preview
Go deeper on NCT01307436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01307436.